IRIS Accounts Production v25.4.0.155 04168544 director 1.4.24 31.3.25 31.3.25 22.12.25 true false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh041685442024-03-31041685442025-03-31041685442024-04-012025-03-31041685442023-03-31041685442023-04-012024-03-31041685442024-03-3104168544ns15:EnglandWales2024-04-012025-03-3104168544ns14:PoundSterling2024-04-012025-03-3104168544ns10:Director12024-04-012025-03-3104168544ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3104168544ns10:SmallEntities2024-04-012025-03-3104168544ns10:Audited2024-04-012025-03-3104168544ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3104168544ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3104168544ns10:FullAccounts2024-04-012025-03-3104168544ns10:RegisteredOffice2024-04-012025-03-3104168544ns5:CurrentFinancialInstruments2025-03-3104168544ns5:CurrentFinancialInstruments2024-03-3104168544ns5:Non-currentFinancialInstruments2025-03-3104168544ns5:Non-currentFinancialInstruments2024-03-3104168544ns5:ShareCapital2025-03-3104168544ns5:ShareCapital2024-03-3104168544ns5:SharePremium2025-03-3104168544ns5:SharePremium2024-03-3104168544ns5:RetainedEarningsAccumulatedLosses2025-03-3104168544ns5:RetainedEarningsAccumulatedLosses2024-03-3104168544ns5:LeaseholdImprovements2024-04-012025-03-3104168544ns5:ComputerEquipment2024-04-012025-03-3104168544ns5:LeaseholdImprovements2024-03-3104168544ns5:ComputerEquipment2024-03-3104168544ns5:LeaseholdImprovements2025-03-3104168544ns5:ComputerEquipment2025-03-3104168544ns5:LeaseholdImprovements2024-03-3104168544ns5:ComputerEquipment2024-03-3104168544ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3104168544ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3104168544ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-03-3104168544ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-03-3104168544ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-03-3104168544ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-31
REGISTERED NUMBER: 04168544 (England and Wales)















Financial Statements for the Year Ended 31 March 2025

for

Mirage Health Group Ltd

Mirage Health Group Ltd (Registered number: 04168544)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Mirage Health Group Ltd

Company Information
for the Year Ended 31 March 2025







DIRECTOR: J Bishop





REGISTERED OFFICE: 11 Tewin Court
Welwyn Garden City
Hertfordshire
AL7 1AU





REGISTERED NUMBER: 04168544 (England and Wales)





AUDITORS: Godfrey Laws Audit Limited
65 Knowl Piece
Wilbury Way
Hitchin
Hertfordshire
SG4 0TY

Mirage Health Group Ltd (Registered number: 04168544)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,526 2,741

CURRENT ASSETS
Stocks 183,561 102,291
Debtors 5 247,518 255,110
Cash in hand 10,178 10,178
441,257 367,579
CREDITORS
Amounts falling due within one year 6 180,460 168,383
NET CURRENT ASSETS 260,797 199,196
TOTAL ASSETS LESS CURRENT
LIABILITIES

262,323

201,937

CREDITORS
Amounts falling due after more than one
year

7

1,768

12,155
NET ASSETS 260,555 189,782

CAPITAL AND RESERVES
Called up share capital 4 4
Share premium 17,500 17,500
Retained earnings 243,051 172,278
SHAREHOLDERS' FUNDS 260,555 189,782

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 December 2025 and were signed by:





J Bishop - Director


Mirage Health Group Ltd (Registered number: 04168544)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Mirage Health Group Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 25% on cost
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Mirage Health Group Ltd (Registered number: 04168544)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 7 ) .

4. TANGIBLE FIXED ASSETS
Improvements
to Computer
property equipment Totals
£    £    £   
COST
At 1 April 2024
and 31 March 2025 3,034 580 3,614
DEPRECIATION
At 1 April 2024 692 181 873
Charge for year 1,115 100 1,215
At 31 March 2025 1,807 281 2,088
NET BOOK VALUE
At 31 March 2025 1,227 299 1,526
At 31 March 2024 2,342 399 2,741

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 18,686 71,839
Other debtors 941 941
Directors' current accounts 74,701 56,189
VAT 1,151 -
Deferred tax asset 146,595 120,260
Prepayments and accrued income 5,444 5,881
247,518 255,110

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Bank loans and overdrafts 43,626 24,122
Trade creditors 120,914 63,389
Social security and other taxes 3,820 3,365
VAT - 10,252
Other creditors 4,600 3,151
Accruals and deferred income 7,500 7,500
Accrued expenses - 56,604
180,460 168,383

Mirage Health Group Ltd (Registered number: 04168544)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.25 31.3.24
£    £   
Bank loans - 1-2 years 1,768 10,387
Bank loans - 2-5 years - 1,768
1,768 12,155

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Howard Ashmore FCA (Senior Statutory Auditor)
for and on behalf of Godfrey Laws Audit Limited

9. CAPITAL COMMITMENTS
31.3.25 31.3.24
£    £   
Contracted but not provided for in the
financial statements 136,292 23,303

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

As at the balance sheet date, the director owed £74,701 (2024: £56,189) to the company. Interest has been charged on the loan at 2.25%. The loan is unsecured and repayable on demand.

11. ULTIMATE CONTROLLING PARTY

The controlling party is J Bishop.